Global Endocannabinoid System Targeted Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 919297 | Published Date: Sep 2024 | No. of Page: 109 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Oral
        1.2.3 Inhalation
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Endocannabinoid System Targeted Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Autoimmune Disorders
        1.3.3 Genetic Disorders
        1.3.4 Neurological Disorders
        1.3.5 Pain Disorders
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Endocannabinoid System Targeted Therapeutics Market Perspective (2016-2027)
    2.2 Endocannabinoid System Targeted Therapeutics Growth Trends by Regions
        2.2.1 Endocannabinoid System Targeted Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Endocannabinoid System Targeted Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Endocannabinoid System Targeted Therapeutics Industry Dynamic
        2.3.1 Endocannabinoid System Targeted Therapeutics Market Trends
        2.3.2 Endocannabinoid System Targeted Therapeutics Market Drivers
        2.3.3 Endocannabinoid System Targeted Therapeutics Market Challenges
        2.3.4 Endocannabinoid System Targeted Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Endocannabinoid System Targeted Therapeutics Players by Revenue
        3.1.1 Global Top Endocannabinoid System Targeted Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Endocannabinoid System Targeted Therapeutics Revenue
    3.4 Global Endocannabinoid System Targeted Therapeutics Market Concentration Ratio
        3.4.1 Global Endocannabinoid System Targeted Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Endocannabinoid System Targeted Therapeutics Revenue in 2020
    3.5 Endocannabinoid System Targeted Therapeutics Key Players Head office and Area Served
    3.6 Key Players Endocannabinoid System Targeted Therapeutics Product Solution and Service
    3.7 Date of Enter into Endocannabinoid System Targeted Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Endocannabinoid System Targeted Therapeutics Breakdown Data by Type
    4.1 Global Endocannabinoid System Targeted Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Type (2022-2027)

5 Endocannabinoid System Targeted Therapeutics Breakdown Data by Application
    5.1 Global Endocannabinoid System Targeted Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Endocannabinoid System Targeted Therapeutics Market Size (2016-2027)
    6.2 North America Endocannabinoid System Targeted Therapeutics Market Size by Type
        6.2.1 North America Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2027)
    6.3 North America Endocannabinoid System Targeted Therapeutics Market Size by Application
        6.3.1 North America Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2027)
    6.4 North America Endocannabinoid System Targeted Therapeutics Market Size by Country
        6.4.1 North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Endocannabinoid System Targeted Therapeutics Market Size (2016-2027)
    7.2 Europe Endocannabinoid System Targeted Therapeutics Market Size by Type
        7.2.1 Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Endocannabinoid System Targeted Therapeutics Market Size by Application
        7.3.1 Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country
        7.4.1 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Endocannabinoid System Targeted Therapeutics Market Size (2016-2027)
    9.2 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Type
        9.2.1 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Application
        9.3.1 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country
        9.4.1 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 GW Pharmaceuticals
        11.1.1 GW Pharmaceuticals Company Details
        11.1.2 GW Pharmaceuticals Business Overview
        11.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
        11.1.4 GW Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
        11.1.5 GW Pharmaceuticals Recent Development
    11.2 MAKScientific
        11.2.1 MAKScientific Company Details
        11.2.2 MAKScientific Business Overview
        11.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Introduction
        11.2.4 MAKScientific Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
        11.2.5 MAKScientific Recent Development
    11.3 Corbus Pharmaceuticals
        11.3.1 Corbus Pharmaceuticals Company Details
        11.3.2 Corbus Pharmaceuticals Business Overview
        11.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
        11.3.4 Corbus Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
        11.3.5 Corbus Pharmaceuticals Recent Development
    11.4 Tilray
        11.4.1 Tilray Company Details
        11.4.2 Tilray Business Overview
        11.4.3 Tilray Endocannabinoid System Targeted Therapeutics Introduction
        11.4.4 Tilray Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
        11.4.5 Tilray Recent Development
    11.5 Pure Green
        11.5.1 Pure Green Company Details
        11.5.2 Pure Green Business Overview
        11.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Introduction
        11.5.4 Pure Green Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
        11.5.5 Pure Green Recent Development
    11.6 Avicanna
        11.6.1 Avicanna Company Details
        11.6.2 Avicanna Business Overview
        11.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Introduction
        11.6.4 Avicanna Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
        11.6.5 Avicanna Recent Development
    11.7 GB Sciences
        11.7.1 GB Sciences Company Details
        11.7.2 GB Sciences Business Overview
        11.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Introduction
        11.7.4 GB Sciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
        11.7.5 GB Sciences Recent Development
    11.8 Botanix Pharmaceuticals
        11.8.1 Botanix Pharmaceuticals Company Details
        11.8.2 Botanix Pharmaceuticals Business Overview
        11.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
        11.8.4 Botanix Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
        11.8.5 Botanix Pharmaceuticals Recent Development
    11.9 Therapix Biosciences
        11.9.1 Therapix Biosciences Company Details
        11.9.2 Therapix Biosciences Business Overview
        11.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Introduction
        11.9.4 Therapix Biosciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
        11.9.5 Therapix Biosciences Recent Development
    11.10 Zelira Therapeutics
        11.10.1 Zelira Therapeutics Company Details
        11.10.2 Zelira Therapeutics Business Overview
        11.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Introduction
        11.10.4 Zelira Therapeutics Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
        11.10.5 Zelira Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Oral
    Table 3. Key Players of Inhalation
    Table 4. Key Players of Others
    Table 5. Global Endocannabinoid System Targeted Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Endocannabinoid System Targeted Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Endocannabinoid System Targeted Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Endocannabinoid System Targeted Therapeutics Market Share by Regions (2016-2021)
    Table 9. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Endocannabinoid System Targeted Therapeutics Market Share by Regions (2022-2027)
    Table 11. Endocannabinoid System Targeted Therapeutics Market Trends
    Table 12. Endocannabinoid System Targeted Therapeutics Market Drivers
    Table 13. Endocannabinoid System Targeted Therapeutics Market Challenges
    Table 14. Endocannabinoid System Targeted Therapeutics Market Restraints
    Table 15. Global Endocannabinoid System Targeted Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Endocannabinoid System Targeted Therapeutics Market Share by Players (2016-2021)
    Table 17. Global Top Endocannabinoid System Targeted Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2020)
    Table 18. Ranking of Global Top Endocannabinoid System Targeted Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Endocannabinoid System Targeted Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Endocannabinoid System Targeted Therapeutics Product Solution and Service
    Table 22. Date of Enter into Endocannabinoid System Targeted Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2016-2021)
    Table 26. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Endocannabinoid System Targeted Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Application (2016-2021)
    Table 30. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. GW Pharmaceuticals Company Details
    Table 63. GW Pharmaceuticals Business Overview
    Table 64. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product
    Table 65. GW Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
    Table 66. GW Pharmaceuticals Recent Development
    Table 67. MAKScientific Company Details
    Table 68. MAKScientific Business Overview
    Table 69. MAKScientific Endocannabinoid System Targeted Therapeutics Product
    Table 70. MAKScientific Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
    Table 71. MAKScientific Recent Development
    Table 72. Corbus Pharmaceuticals Company Details
    Table 73. Corbus Pharmaceuticals Business Overview
    Table 74. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product
    Table 75. Corbus Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
    Table 76. Corbus Pharmaceuticals Recent Development
    Table 77. Tilray Company Details
    Table 78. Tilray Business Overview
    Table 79. Tilray Endocannabinoid System Targeted Therapeutics Product
    Table 80. Tilray Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
    Table 81. Tilray Recent Development
    Table 82. Pure Green Company Details
    Table 83. Pure Green Business Overview
    Table 84. Pure Green Endocannabinoid System Targeted Therapeutics Product
    Table 85. Pure Green Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
    Table 86. Pure Green Recent Development
    Table 87. Avicanna Company Details
    Table 88. Avicanna Business Overview
    Table 89. Avicanna Endocannabinoid System Targeted Therapeutics Product
    Table 90. Avicanna Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
    Table 91. Avicanna Recent Development
    Table 92. GB Sciences Company Details
    Table 93. GB Sciences Business Overview
    Table 94. GB Sciences Endocannabinoid System Targeted Therapeutics Product
    Table 95. GB Sciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
    Table 96. GB Sciences Recent Development
    Table 97. Botanix Pharmaceuticals Company Details
    Table 98. Botanix Pharmaceuticals Business Overview
    Table 99. Botanix Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. Botanix Pharmaceuticals Recent Development
    Table 101. Therapix Biosciences Company Details
    Table 102. Therapix Biosciences Business Overview
    Table 103. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product
    Table 104. Therapix Biosciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
    Table 105. Therapix Biosciences Recent Development
    Table 106. Zelira Therapeutics Company Details
    Table 107. Zelira Therapeutics Business Overview
    Table 108. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product
    Table 109. Zelira Therapeutics Revenue in Endocannabinoid System Targeted Therapeutics Business (2016-2021) & (US$ Million)
    Table 110. Zelira Therapeutics Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Endocannabinoid System Targeted Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Oral Features
    Figure 3. Inhalation Features
    Figure 4. Others Features
    Figure 5. Global Endocannabinoid System Targeted Therapeutics Market Share by Application: 2020 VS 2027
    Figure 6. Autoimmune Disorders Case Studies
    Figure 7. Genetic Disorders Case Studies
    Figure 8. Neurological Disorders Case Studies
    Figure 9. Pain Disorders Case Studies
    Figure 10. Endocannabinoid System Targeted Therapeutics Report Years Considered
    Figure 11. Global Endocannabinoid System Targeted Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Endocannabinoid System Targeted Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Endocannabinoid System Targeted Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 14. Global Endocannabinoid System Targeted Therapeutics Market Share by Regions (2022-2027)
    Figure 15. Global Endocannabinoid System Targeted Therapeutics Market Share by Players in 2020
    Figure 16. Global Top Endocannabinoid System Targeted Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Endocannabinoid System Targeted Therapeutics Revenue in 2020
    Figure 18. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 19. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 20. North America Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Endocannabinoid System Targeted Therapeutics Market Share by Type (2016-2027)
    Figure 22. North America Endocannabinoid System Targeted Therapeutics Market Share by Application (2016-2027)
    Figure 23. North America Endocannabinoid System Targeted Therapeutics Market Share by Country (2016-2027)
    Figure 24. United States Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Endocannabinoid System Targeted Therapeutics Market Share by Type (2016-2027)
    Figure 28. Europe Endocannabinoid System Targeted Therapeutics Market Share by Application (2016-2027)
    Figure 29. Europe Endocannabinoid System Targeted Therapeutics Market Share by Country (2016-2027)
    Figure 30. Germany Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Share by Region (2016-2027)
    Figure 40. China Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Endocannabinoid System Targeted Therapeutics Market Share by Type (2016-2027)
    Figure 48. Latin America Endocannabinoid System Targeted Therapeutics Market Share by Application (2016-2027)
    Figure 49. Latin America Endocannabinoid System Targeted Therapeutics Market Share by Country (2016-2027)
    Figure 50. Mexico Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Share by Country (2016-2027)
    Figure 56. Turkey Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. GW Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
    Figure 60. MAKScientific Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
    Figure 61. Corbus Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
    Figure 62. Tilray Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
    Figure 63. Pure Green Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
    Figure 64. Avicanna Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
    Figure 65. GB Sciences Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
    Figure 66. Botanix Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
    Figure 67. Therapix Biosciences Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
    Figure 68. Zelira Therapeutics Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GW Pharmaceuticals
MAKScientific
Corbus Pharmaceuticals
Tilray
Pure Green
Avicanna
GB Sciences
Botanix Pharmaceuticals
Therapix Biosciences
Zelira Therapeutics
Frequently Asked Questions
Endocannabinoid System Targeted Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Endocannabinoid System Targeted Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Endocannabinoid System Targeted Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports